PRAX - Praxis Precision Medicines, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$549.80
DETAILS
HIGH:
$843.00
LOW:
$166.00
MEDIAN:
$500.00
CONSENSUS:
$549.80
UPSIDE:
60.03%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue | 0 | 8.6 | 2.4 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0.1 | 152.4 | 86.8 | 154.4 | 0 | 0 | 0.7 | 0.0 |
| Gross Profit | (0.1) | (143.9) | (84.3) | (154.4) | 0 | 0 | (0.7) | (0.0) |
| Operating Expenses | ||||||||
| R&D Expenses | 267.1 | 152.4 | 86.8 | 155.0 | 120.3 | 45.0 | 29.6 | 18.8 |
| SG&A Expenses | 59.1 | 56.3 | 42.1 | 59.5 | 47.1 | 17.0 | 6.2 | 3.9 |
| Other Expenses | 0 | (152.4) | (86.8) | (154.0) | 0 | 0 | 0 | 0 |
| Operating Expenses | 326.1 | 56.3 | 42.1 | 60.5 | 167.3 | 62.0 | 35.8 | 22.7 |
| Operating Income | ||||||||
| Operating Income | (326.2) | (200.2) | (126.4) | (215.0) | (167.3) | (62.0) | (35.8) | (22.7) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 |
| Interest Income | 22.9 | 17.3 | 0 | 0 | 0 | 0.1 | 0.2 | 0.1 |
| Profitability | ||||||||
| EBITDA | (303.1) | (199.8) | (125.9) | (213.6) | (167.2) | (61.9) | (34.9) | (26.3) |
| EBIT | (303.3) | (200.2) | (126.4) | (214.0) | (167.3) | (62.0) | (35.6) | (26.3) |
| Income Before Tax | (303.3) | (182.8) | (123.3) | (214.0) | (167.1) | (61.8) | (35.6) | (26.4) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | (0.0) | (0.1) | 0.1 |
| Net Income | (303.3) | (182.8) | (123.3) | (214.0) | (167.1) | (61.8) | (35.5) | (26.5) |
| Per Share Data | ||||||||
| EPS (Basic) | -13.48 | -10.21 | -18.69 | -69.33 | -58.96 | -103.61 | -348.24 | -306.73 |
| EPS (Diluted) | -13.48 | -10.21 | -18.69 | -69.33 | -58.96 | -103.61 | -348.24 | -306.73 |
| Shares Outstanding | 22.5 | 17.9 | 6.6 | 3.1 | 2.8 | 0.6 | 0.1 | 0.1 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||
| Cash & Cash Equivalents | 357.3 | 215.4 | 81.3 | 61.6 | 138.7 | 296.6 | 44.8 | 17.9 |
| Short-Term Investments | 242.0 | 177.2 | 0 | 38.9 | 137.2 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 11.6 | 11.8 | 3.6 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 610.9 | 404.4 | 84.9 | 110.8 | 287.4 | 302.3 | 45.5 | 19.1 |
| Non-Current Assets | ||||||||
| Property, Plant & Equipment | 0.2 | 1.4 | 2.7 | 3.9 | 4.9 | 0.8 | 1.6 | 0.1 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 77.0 | 0 | 0 | 0 | 0 | 0 | 0.6 |
| Other Non-Current Assets | 326.8 | 0.4 | 0.4 | 0.4 | 0.5 | 0.0 | 0.6 | 0 |
| Total Non-Current Assets | 327.0 | 78.7 | 3.1 | 4.3 | 5.3 | 0.9 | 2.2 | 0.7 |
| Total Assets | 937.9 | 483.1 | 87.9 | 115.1 | 292.7 | 303.2 | 47.7 | 19.8 |
| Current Liabilities | ||||||||
| Account Payables | 24.6 | 12.5 | 5.8 | 14.7 | 10.8 | 4.1 | 2.7 | 3.4 |
| Short-Term Debt | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 1.4 | 2.8 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 35.0 | 9.4 | 3.7 | 2.8 | 7.2 | 0 | 0 | 1.0 |
| Total Current Liabilities | 59.8 | 37.5 | 15.7 | 34.3 | 38.4 | 15.7 | 6.8 | 5.1 |
| Non-Current Liabilities | ||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 |
| Total Non-Current Liabilities | 0 | 0.1 | 2.5 | 4.7 | 3.5 | 0 | 0.8 | 0.0 |
| Total Liabilities | 59.8 | 37.7 | 18.3 | 39.0 | 41.9 | 15.7 | 7.6 | 5.1 |
| Stockholders' Equity | ||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (1,140.0) | (836.7) | (653.9) | (530.6) | (316.6) | (149.6) | (81.0) | (41.4) |
| Accumulated Other Comprehensive Income | 0 | 0.7 | 0 | (0.2) | (0.2) | 0 | 0 | (0.0) |
| Total Stockholders' Equity | 878.1 | 445.4 | 69.7 | 76.1 | 250.8 | 287.5 | 40.1 | 14.7 |
| Total Liabilities & Equity | 937.9 | 483.1 | 87.9 | 115.1 | 292.7 | 303.2 | 47.7 | 19.8 |
| Debt Metrics | ||||||||
| Total Debt | 0.1 | 1.4 | 2.5 | 3.5 | 4.3 | 0.8 | 1.5 | 0 |
| Net Debt | (357.2) | (214.0) | (78.8) | (58.1) | (134.4) | (295.8) | (43.4) | (17.9) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | (303.3) | (182.8) | (123.3) | (214.0) | (167.1) | (61.8) | (35.5) | (26.5) |
| Depreciation & Amortization | (3.5) | 0.4 | 0.4 | 0.4 | 0.2 | 0.1 | 0.7 | 0.0 |
| Stock-Based Compensation | 33.9 | 41.4 | 24.9 | 28.6 | 22.7 | 5.2 | 0 | 0.6 |
| Change in Working Capital | 22.7 | 10.9 | (13.0) | (1.8) | 16.1 | 3.2 | 1.4 | 1.5 |
| Other Non-Cash Items | 1.0 | (1.6) | (0.1) | 1.8 | 1.4 | 0.7 | 0.7 | 0.1 |
| Operating Cash Flow | (249.1) | (131.8) | (111.1) | (185.0) | (124.6) | (52.6) | (32.8) | (20.7) |
| Investing Activities | ||||||||
| Capital Expenditure | (0.1) | 0 | (0.1) | (0.4) | (1.1) | 0 | (0.1) | (0.1) |
| Acquisitions | 0 | 0 | 0 | (97.3) | 139.5 | 0 | 0 | 0 |
| Purchases of Investments | (623.8) | (371.5) | 0 | (83.0) | (164.2) | 0 | 0 | 0 |
| Sales/Maturities of Investments | 312.7 | 123.0 | 39 | 180.4 | 24.7 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 97.3 | (139.5) | 0 | 0 | 0 |
| Investing Cash Flow | (311.1) | (248.5) | 39.0 | 96.9 | (140.5) | 0 | (0.1) | (0.1) |
| Financing Activities | ||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | (0.8) | 0 | (0.6) | 1 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | (30) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (2.1) | 2.3 | 0.3 | 0.9 | 2.6 | 0.1 | 0 | 0 |
| Financing Cash Flow | 702.2 | 514.3 | 91.9 | 10.5 | 107.6 | 304.4 | 59.8 | 37.8 |
| Cash Position | ||||||||
| Net Change in Cash | 142.0 | 134.1 | 19.7 | (77.7) | (157.5) | 251.8 | 26.9 | 17.0 |
| Cash at Beginning | 215.8 | 81.7 | 62.0 | 139.7 | 297.2 | 45.4 | 17.9 | 1.5 |
| Cash at End | 357.7 | 215.8 | 81.7 | 62.0 | 139.7 | 297.2 | 44.8 | 18.6 |
| Free Cash Flow | (249.1) | (131.8) | (111.2) | (185.5) | (125.6) | (52.6) | (32.9) | (20.8) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0 | 8.6 | 2.4 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | (0.1) | (143.9) | (84.3) | (154.4) | 0 | 0 | (0.7) | (0.0) |
| Operating Income | (326.2) | (200.2) | (126.4) | (215.0) | (167.3) | (62.0) | (35.8) | (22.7) |
| Net Income | (303.3) | (182.8) | (123.3) | (214.0) | (167.1) | (61.8) | (35.5) | (26.5) |
| EPS (Diluted) | -13.48 | -10.21 | -18.69 | -69.33 | -58.96 | -103.61 | -348.24 | -306.73 |
| Balance Sheet | ||||||||
| Cash & Equivalents | 357.3 | 215.4 | 81.3 | 61.6 | 138.7 | 296.6 | 44.8 | 17.9 |
| Total Assets | 937.9 | 483.1 | 87.9 | 115.1 | 292.7 | 303.2 | 47.7 | 19.8 |
| Total Debt | 0.1 | 1.4 | 2.5 | 3.5 | 4.3 | 0.8 | 1.5 | 0 |
| Stockholders' Equity | 878.1 | 445.4 | 69.7 | 76.1 | 250.8 | 287.5 | 40.1 | 14.7 |
| Cash Flow | ||||||||
| Operating Cash Flow | (249.1) | (131.8) | (111.1) | (185.0) | (124.6) | (52.6) | (32.8) | (20.7) |
| Capital Expenditure | (0.1) | 0 | (0.1) | (0.4) | (1.1) | 0 | (0.1) | (0.1) |
| Free Cash Flow | (249.1) | (131.8) | (111.2) | (185.5) | (125.6) | (52.6) | (32.9) | (20.8) |